Ozempic®: a new therapeutic option for type 2 diabetes patients

被引：0
|
作者：
Coquard-Schmidt, Barbara
机构：
来源：
CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION | 2019年 / 23卷 / 4-5期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：139 / 139
页数：1
相关论文
共 50 条
  • [31] Systematic therapeutic intervention for type 2 diabetes patients
    Vintila, M.
    Istrat, D.
    Kuglis, A.
    PSYCHOLOGY & HEALTH, 2010, 25 : 363 - 364
  • [32] Vitamin D-A New Therapeutic Target in the Management of Type 2 Diabetes Patients
    Albai, Oana
    Braha, Adina
    Timar, Bogdan
    Golu, Ioana
    Timar, Romulus
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (05)
  • [33] Bariatric surgery as a treatment option in patients with type 2 diabetes mellitus
    Spanou, Marianna
    Tziomalos, Konstantinos
    WORLD JOURNAL OF DIABETES, 2013, 4 (02) : 14 - 18
  • [34] Semaglutide as a therapeutic option for elderly patients with type 2 diabetes: Pooled analysis of the SUSTAIN 1-5 trials
    Warren, Mark
    Chaykin, Louis
    Trachtenbarg, David
    Nayak, Gurudutt
    Wijayasinghe, Nelun
    Cariou, Bertrand
    DIABETES OBESITY & METABOLISM, 2018, 20 (09): : 2291 - 2297
  • [35] Thrice daily biphasic insulin aspart 30 regimen: another therapeutic option for Chinese patients with Type 2 diabetes
    Yang, Wenying
    Ji, Qiuhe
    Zhu, Dalong
    Yang, Jinkui
    Chen, Lulu
    Liu, Zhimin
    Yu, Demin
    Yan, Li
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 79 : S67 - S67
  • [36] SGLT-2 inhibition with canagliflozin: A new option for the treatment of type 2 diabetes
    Seufert, J.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2014, 139 : S52 - S58
  • [37] Pancreatic islet transplantation a new therapeutic option in diabetes mellitus
    Popow, Anna
    Durlik, Marek
    Rydzewski, Andrzej
    PRZEGLAD GASTROENTEROLOGICZNY, 2006, 1 (04): : 202 - 207
  • [38] Inhaled insulin -: a new therapeutic option in the treatment of diabetes mellitus
    Díez, JJ
    Iglesias, P
    EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (02) : 191 - 200
  • [39] Semaglutide (Ozempic) - Another Injectable GLP-1 Receptor Agonist for Type 2 Diabetes
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2018, 60 (1539): : 19 - 21
  • [40] Is a new therapeutic class justified in the treatment of type 2 diabetes?
    Halimi, S
    ANNALES D ENDOCRINOLOGIE, 2002, 63 (02) : S7 - S11
12345